The impact of iron overload and its treatment on quality of life: results from a literature review.
about
Oral deferiprone for iron chelation in people with thalassaemiaFactors affecting health-related quality of life in Thai children with thalassemia.Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai childrenQuality of life in patients with thalassemia major.Life Satisfaction in children and adolescents with beta thalassemia major in southwest IranPhosphoproteomic analysis of apoptotic hematopoietic stem cells from hemoglobin E/β-thalassemia.Combined histological and hematological assessment of iron-induced organ damage in a gerbil model of iron overloadCombined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded RatsPsychometric properties of the Specific Thalassemia Quality of Life Instrument for adultsComparative effects of three iron chelation therapies on the quality of life of greek patients with homozygous transfusion-dependent Beta-thalassemia.Geographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemiasCost-utility analysis of deferiprone for the treatment of β-thalassaemia patients with chronic iron overload: a UK perspectiveInterventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemiaManagement of transfusional iron overload in Latin America: current outlook and expert panel recommendations.Which psychosocial factors are related to chelation adherence in thalassemia? A systematic review.Toward resolving the unsettled role of iron chelation therapy in myelodysplastic syndromes.Deferasirox: a review of its use for chronic iron overload in patients with non-transfusion-dependent thalassaemia.Comparison of Quality of Life in Patients with β-Thalassemia Intermedia and β-Thalassemia Major in Southern Iran.Quality of Life Outcomes in a Pediatric Thalassemia Population in Egypt.Impact of educational programme regarding chelation therapy on the quality of life for B-thalassemia major children.Iron chelation therapy in low risk myelodysplastic syndrome.Cost-Utility Analysis of Three Iron Chelators Used in Monotherapy for the Treatment of Chronic Iron Overload in β-Thalassaemia Major Patients: An Italian Perspective.A new tool for the assessment of satisfaction with iron chelation therapy (ICT-Sat) for patients with β-thalassemia major.Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical TrialSocio-psychological impact of infused iron chelation therapy with deferoxamine in metropolitan France: ISOSFER study results.Persistence and compliance of deferoxamine versus deferasirox in Medicaid patients with sickle-cell disease.Executive function and neural activation in adults with β-thalassemia major: an event-related potentials study.Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT.Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia.Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia
P2860
Q24200309-091DC2E3-420F-46F1-9226-DBC31CC4BEE5Q33533903-DCF4368B-6325-487B-A164-036D761E1E4FQ33533943-041F4C96-3BE6-4FFD-B8B4-0B724B4D1836Q33850985-D7B10C6E-3949-42B5-B966-3FC9302C9304Q35072230-072DDCC9-6585-49E3-B775-F37C0EF54D65Q35124711-246F3C25-F8DA-4F7E-B6C0-A17D1E988A83Q35440224-89600A5D-BFB7-46C8-8B60-67D21EF1274CQ36080315-9588A49F-03FF-4B51-9E40-BA0F13FD0FC7Q36108486-DA34EC59-8B03-4FB5-88C1-9D6EBEDAC48DQ36500199-DD4B5CE3-1309-434D-99C8-68902AD74958Q36569047-F0A28988-B744-4269-BD8F-95F507423D82Q37132320-D6F5367C-7CE9-4CF6-AC02-E89E021D4380Q37305389-CF63FB06-294B-49D4-B754-9A9A4AF0FD12Q37372868-422C0C66-E5BB-4DAF-86A4-B2A48192591DQ37762810-ECC68F9B-1855-4DB8-B72A-255D9440341EQ38196963-A2C5856C-628F-41AA-8F49-F9EFB0ACF7E3Q38219588-5A0490D9-05FB-47D0-9D33-915D8EC0141AQ38662673-5961C18E-65C2-47EC-83B6-2A983C492CC0Q38821391-2722E93D-3279-4B73-BEB5-8CB712192934Q38858532-8DF7CC1F-428F-44D5-AB95-ED1A0EED11CBQ38903926-A7CC3FD3-D1EF-460A-9CF7-ACBDC10FC2B9Q38968558-D46BEE0D-3EC0-41EC-8029-4CE11F261FC5Q38990649-2694A455-99FD-455C-A6DE-3147DDE6D06EQ42098491-A5C08FC6-8B3A-467C-8CC9-B7854E661B89Q43235022-8508C0B4-FC11-4D67-BF7D-CF3A271021B9Q44101608-DA497A39-386A-434D-BBE9-44EE512FE168Q48447556-C2BEA4CA-F6E7-482F-9C25-716F47C88AA4Q53142347-4558C52D-317C-4E8F-8986-CBEE88A9E768Q54963190-3A37B029-DEEA-4E3B-AE2D-CC355820ADE3Q56389520-6F663986-EDC9-43BE-A58A-73C9999D4F33
P2860
The impact of iron overload and its treatment on quality of life: results from a literature review.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The impact of iron overload an ...... ults from a literature review.
@ast
The impact of iron overload an ...... ults from a literature review.
@en
type
label
The impact of iron overload an ...... ults from a literature review.
@ast
The impact of iron overload an ...... ults from a literature review.
@en
prefLabel
The impact of iron overload an ...... ults from a literature review.
@ast
The impact of iron overload an ...... ults from a literature review.
@en
P2093
P2860
P921
P356
P1476
The impact of iron overload an ...... ults from a literature review.
@en
P2093
Diana Rofail
Jean-Francois Baladi
Linda Abetz
Paula Jones
P2860
P2888
P356
10.1186/1477-7525-4-73
P5008
P577
2006-09-28T00:00:00Z
P5875
P6179
1047285486